Precise regulatory mechanisms are required to appropriately modulate the cellular levels of transcription factors controlling cell fate decisions during blood cell development. In this study, we show that miR-126 is a novel physiological regulator of the proto-oncogene c-myb during definitive hematopoiesis. We show that knockdown of miR-126 results in increased c-Myb levels and promotes erythropoiesis at the expense of thrombopoiesis in vivo. We further provide evidence that specification of thrombocyte versus erythrocyte cell lineages is altered by the concerted activities of the microRNAs (miRNAs) miR-126 and miR-150. Both miRNAs are required but not sufficient individually to precisely regulate the cell fate decision between erythroid and megakaryocytic lineages during definitive hematopoiesis in vivo. These results support the notion that miRNAs not only function to provide precision to developmental programs but also are essential determinants in the control of variable potential functions of a single gene during hematopoiesis.
Introduction
The determination of hematopoietic lineages heavily relies on regulation at the transcriptional level, and the functional roles of many transcription factors that are essential for hematopoietic specification have been well established. [1] [2] [3] [4] Throughout hematopoietic development, the cellular levels of these transcription factors undergo dynamic changes that affect lineage specification as well as the proliferation and maturation of a given cell type. 5 The c-Myb protein is a major hematopoietic transcription factor whose levels must be precisely controlled during normal blood cell development, and whose aberrant expression contributes to leukemogenesis. 6-10 c-Myb functions at multiple stages of blood cell development from hematopoietic stem cells (HSCs) and progenitor cells to fully differentiated cell types, and can affect the definitive specification of lymphoid, myeloid, erythroid and megakaryocyte lineages. Given the spatiotemporal diversity of its developmental roles, the mechanisms controlling the timing and levels of c-Myb activity must be precise and tightly maintained. Although the c-Myb protein has a very short half-life, the regulatory control of its degradation, synthesis and mRNA stability remains poorly understood.
MicroRNAs (miRNAs) provide an elegant mechanism that affords finely tuned control of protein levels by controlling translational efficacy and mRNA stability. 11 These non-coding small RNA molecules are quickly becoming recognized as key regulators of diverse cellular functions, including the specification and differentiation of hematopoietic cells. 12 The c-myb 3 0 untranslated region (UTR) contains predicted target sites for more than a dozen miRNAs. [13] [14] [15] Up to date, regulation of c-Myb by two of these miRNAs has been experimentally validated. The overexpression of miR-15 inhibits c-myb 3 0 UTR-dependent luciferase activity in vitro, and contributes to the inhibition of erythroid and myeloid colony formation. 16 Overexpression studies of miR-150 in vitro, using a luciferase reporter gene containing the c-myb 3 0 UTR, also result in a reduction in luciferase activity. miR-150-deficient mice show an increase in B1 cells that are known to require c-Myb; 17 an increase in c-Myb protein level was also seen in miR-150deficient activated B cells. These findings support the role of miR-150/c-myb interactions in B-cell maintenance and differentiation. 18 Gain-and loss-of-function analyses have shown that the miR-150/c-myb interaction is also essential for the lineage decision of megakaryocyte-erythrocyte progenitor cells to form either megakaryocytes or erythrocytes in vitro. 19 Overall, these observations indicate that variations in the levels of c-Myb may be differentially controlled by multiple miRNAs to execute lineage-specific developmental programs at critical junctions during hematopoiesis. Nevertheless, possible combinatorial effects of multiple miRNAs regulating c-Myb within the same developmental context have yet to be addressed experimentally.
Zebrafish and mammalian hematopoiesis are highly conserved on molecular and cellular levels, and the phases corresponding to mammalian embryonic and fetal hematopoiesis occur rapidly in the zebrafish with definitive hematopoiesis predominating by 5 days post fertilization (d.p.f). Therefore, zebrafish provide an ideal system to study the function of miRNAs on different cell lineages at specific hematopoietic stages. 20 Furthermore, zebrafish are amenable to transient gene knockdown assays using antisense morpholinos (MOs) and forced mRNA expression analyses, which provide major advantages for studying mechanisms of miRNA activities regulating embryonic development. 21, 22 Hematopoietic development in zebrafish occurs in four distinct waves, the first two are termed 'primitive', generating macrophages and erythrocytes before 30 h post fertilization (h.p.f.). Two 'definitive' waves follow; first, erythromyeloid progenitors form at 30 h.p.f within the caudal hematopoietic tissue or posterior blood island. At 32-36 h.p.f., the second wave generates HSCs from endothelial cells lining the ventral wall of the dorsal aorta, a region thought to be comparable with the mammalian aorta-gonad-mesonephros. 23, 24 These HSCs subsequently colonize the caudal hematopoietic tissue and the adult hematopoietic organs, the kidney and thymus. [25] [26] [27] c-Myb is largely dispensable for primitive hematopoiesis, but is essential for definitive blood formation and the normal development of erythroid and megakaryocyte lineages. 28 Importantly, c-Myb is also required in non-hematopoietic tissues and c-Myb loss-or gain-of-function assays in vivo result in severe developmental malformation and embryonic lethality, which can preclude hematopoietic analysis. 29 One approach to circumvent this is by manipulating tissue-specific regulators of c-Myb, which allow the analysis of the functions of c-Myb within a specific developmental context.
In this study, we demonstrate the direct regulation of c-Myb by miR-126, and the importance of the miR-126/c-myb interaction during definitive hematopoiesis in the zebrafish in vivo. We show that precisely regulated levels of c-Myb are responsible for determining the lineage decision between megakaryocyte/thrombocyte and erythrocyte cell fates in the zebrafish. Furthermore, we show that regulation of this cell fate decision depends on the concerted actions of both miR-126 and miR-150, assigning a permissive role to miR-126 to promote megakaryocyte/thrombocyte lineage commitment in vivo.
Materials and methods

Zebrafish
Wild-type AB stocks of Danio rerio, the transgenic lines Tg(c-myb:EGFP), 30 Tg(gata1:dsRed), 31 Tg(cd41:EGFP) 32 and the mutant line Nacre 33 were maintained by standard methods. 34 
MOs and miRNA duplexes
MOs (Gene Tools, LLC, Philomath, OR, USA) were designed to target the mature miR-126 (MO126) and miR-150 (MO150), the Drosha and Dicer sites of pri-miR-126 (MOMB), the putative miR-126 seed sequence in the zf c-myb 3 0 UTR (c-myb-TP miR126 ) and the translational start site of c-myb (MOmyb). The standard control MO from Gene Tools was used as a control (MOctrl). Synthetic miRNA duplexes for miR-126, 150 and 451 were purchased from Dharmacon (Dharmacon Inc., Lafayette, CO, USA) miR-451 was used as a negative control miRNA for target validation studies (miR-ctrl). MOp53 was co-injected with other MOs to abrogate non-specific MO toxicity. 35 MO and miRNA sequences are provided in Table 1 . MOs, miRNA duplexes and mRNAs were injected into the yolk of one-cell-stage embryos. MOs were injected at 8 ng (MO126, MOctrl), 0.6 ng (MO150), 0.8 ng(for fluorescence quantification) or 2 ng (for ISH analyses; c-myb-TPmiR126), 3 ng(MOMB), 2 ng (MOmyb) and 1.6 ng (MOp53); miRNA duplexes were injected at 5-10 mM; mRNAs were transcribed from linearized pCS2 þ and injected at 350 ng/ml (EGFP-c-myb-3 0 UTRwt and mut), 80 ng/ml (mCherry), 100 ng/ml (c-myb).
Whole-mount in situ hybridization
Whole-mount in situ hybridization for mRNAs was performed as described previously. 36 Cloning of zebrafish c-myb complementary DNA and 3 0 UTR and site-directed mutagenesis Full-length complementary DNA of zebrafish (zf) c-myb and c-myb 3 0 UTR were isolated from total RNA by one-step reverse transcriptase PCR (RTPCR; Qiagen, Valencia, CA, USA) and cloned into pCRII, verified by sequencing and subsequently subcloned. Primers for full-length zf-c-myb amplification included a 5 0 BamHI site and a 3 0 EcoRI site to be subcloned into the pCS2 þ expression vector. Primers for the c-myb 3 0 UTR included a 5 0 XhoI site and a 3 0 XbaI site to be subcloned into a pCS2-EGFP expression vector C-terminal to the enhanced green fluorescent protein (EGFP) open reading frame pCS2 þ . Mutated c-myb 3 0 UTR was generated using a site-directed mutagenesis kit (Stratagene, Santa Clara, CA, USA). Oligo sequences are provided in Table 2 .
Cell sorting
Embryos (B150) were collected from Tg(c-myb:EGFP), Tg(cd41:EGFP) Tg(gata1:dsRed) and Tg(gata1:dsRed/cd41:EGFP) at 36 h.p.f. and 4 d.p.f., 31, 32 respectively, and disaggregated into a single cell suspension as previously described. 26 Sorting of c-myb:EGFP þ , cd41:EGFP þ and gata1:dsRed þ cells was performed on a BD FACSAria (Becton Dickenson, Franklin lakes, NJ, USA) and fluorescent-activated cell sorting (FACS) analysis on gata1:dsRed/cd41:EGFP embryo suspensions was collected on a FACScaliber (Becton Dickenson, Franklin lakes, NJ, USA) and analyzed using Flowjo software (Treestar Inc., Ashland, OR, USA).
RNA isolation and RTPCR
Total RNA from whole embryos or sorted cells was extracted with TRIzol (Invitrogen, Carlsbad, CA, USA). Quantitative Table 1 Morpholino and miRNA sequences MO Morpholino sequence
MiRNA duplex (active strand) sequence
Abbreviations: Ctrl, control; MB, multiblocker; miR, micro RNA; MO, morpholino; TP, target protector.
Table 2
Primer sequences
Abbreviations: Fwd, forward; Rev, reverse.
MicroRNA-126 regulates c-Myb in hematopoiesis C Grabher et al RT-PCR was performed using miRScipt RT and SYBR Green PCR and miRScript Primer Assays (Qiagen) according to the manufacturers protocol. All quantitative RT-PCR reactions were performed in triplicates in two independent experiments. Gene expression changes were quantified based on the DDC T method using the relative expression software tool (REST). 37 Oligo sequences are provided in Table 2 .
Protein analysis
Embryos ( 
Fluorescence quantification assays
To determine miRNA regulation of the c-myb 3 0 UTR in live zebrafish embryos, we quantified the relative fluorescence upon co-injections of mRNA of the c-myb 3 0 UTR fused to EGFP, mCherry and various miRs and MOs. Co-injection of mCherryencoding RNA with the c-myb 3 0 UTR:GFP (green fluorescence protein) mRNA was used in all conditions as an intra-embryo injection control. Relative fluorescence was calculated to account for normal variations observed in expression levels of injected mRNAs between embryos (related to minor variations in injection and translation efficiency). All experiments were performed in triplicate. Five representative embryos from each injection set were selected and imaged on a Zeiss Axio Imager Z1 microscope (Carl Zeiss MicroImaging LLC, Thornwood, NY, USA) using a Hamamatsu Orca-ER (Hamamatsu, Bridgewater, NJ, USA) digital camera and Openlab software (Improvision, Perkin-Elmer). To calculate relative fluorescence for each embryo, identical selections from three different body regions were chosen from individual embryos and measured for the sum of their pixel intensity using Volocity software (Improvision). Relative fluorescence was determined for each embryo (S GFP /S mCherry ). These values were then averaged for all embryos analyzed for a given injection condition, normalized to the average relative fluorescence of the control miRNA-injected embryos, and compared with each other to determine the effect of a given injection condition on fluorescence intensity resulting in a readout for miRNA-mRNA interaction in vivo.
Results
To identify novel miRNAs regulating c-Myb, we analyzed the c-myb 3 0 UTR for potential target sites of miRNAs expressed in HSCs. We were particularly interested in miR-126, because it is highly expressed in normal human and murine HSCs and in acute myeloid leukemia leukemia-initiating cells, [38] [39] [40] [41] and is also part of a distinct miRNA overexpression signature in corebinding factor leukemias. 40 Our analysis revealed a putative miR-126 target site within 120 bp downstream of the c-myb stop codon with a perfect seed match that was conserved in three mammalian and two teleost fish species (Figures 1a and b ). Consistent with these findings, the sequence of mature miR-126 was also conserved among these organisms (Figure 1b) , as well as the sequence of miR-150 ( Figure 1c ). Notably, mammalian 3 0 UTRs contained at least two putative miR-150 target sites, whereas zebrafish and medaka 3 0 UTRs had a single perfect seed match for miR-150 ( Figure 1a ). We evaluated the function of the putative miR-126 target site using an in vivo reporter assay in zebrafish embryos. 22 Figure 2a illustrates our reporter assay, in which mRNA encoding the wild-type zebrafish c-myb 3 0 UTR fused to EGFP was co-injected with mCherry mRNA into embryos at the one cell stage. The co-injected mCherry mRNA controlled for injection variability. Changes in levels of EGFP expression relative to mCherry expression were assessed in the presence of various miRNA duplexes (Figure 2b ). Co-injection of miR-126 resulted in a statistically significant decrease (35%) in c-myb 3 0 UTR-EGFP fluorescence compared with co-injected control miRNAs and indicated potent negative regulatory function (Figures 2b and c) . Expression of miR-150 yielded a similar 30% reduction in EGFP fluorescence. To confirm the specificity of these observations, we also performed assays using EGFP fused to a mutated 3 0 UTR that contained four nucleotide substitutions within the miR-126 target seed sequence, or a target protector MO (c-myb-TP miR126) ), which competes with miR-126 for the specific target sequence in the c-myb 3 0 UTR (Figures 1d,e and 2 ). 42 In both cases, GFP fluorescence was restored to control levels (Figures 2b and c) . Interestingly, the co-expression of both miR-126 and miR-150 showed no additive effect on the reduction of GFP fluorescence when compared with either of the miRs expressed independently. Target protector MOs provide an exquisite means to inhibit specific mRNA/miRNA interactions during zebrafish embryonic development without affecting other potential target mRNAs or miRNAs. Given that the miR-126 and miR-150 target sites in both fish species are in close physical proximity within the 3 0 UTR, we verified that c-myb-TP miR126 blocked the miR-126 effects but did not interfere with miR-150-mediated regulation of c-Myb (Figures 2b and c) . Our findings show that miR-126 can interact in vivo with its predicted target site within the c-myb 3 0 UTR to attenuate translation of an upstream coding region.
To demonstrate the physiological relevance of the miR-126/ c-myb interaction, we analyzed c-Myb expression in zebrafish embryos and sorted zebrafish hematopoietic stem/progenitor cells. As in mammals, c-Myb is broadly and dynamically expressed in many tissues, including HSCs of the developing hematopoietic system. 20 Definitive c-myb þ /runx1 þ HSCs appear at B36 h.p.f. within the aorta-gonad-mesonephros, 43 and 4 h later begin to migrate into the kidney and thymus, the adult hematopoietic organs, and the posterior blood island. [25] [26] [27] To analyze c-myb mRNA levels in HSCs on knockdown or forced expression of miR-126 in vivo, we used FACS to isolate EGFP þ HSCs from embryos of the transgenic zebrafish line Tg(cmyb:EGFP), which drives EGFP under the control of the zebrafish c-myb promoter. 30 Figures 3a and b) . A recent report indicated that miR-126 knockdown in zebrafish embryos resulted in a loss of vascular integrity and hemorrhage. 44 However, at the MO concentrations used in this study, (Figure 3a) . The c-myb:EGFP þ cells from these embryos at 36 h.p.f. revealed an expected inverse correlation of miR-126 to c-myb mRNA levels. However, the observed differences in mRNA levels were not statistically significant (Figure 3a ), suggesting that miR-126 primarily regulates c-Myb protein synthesis, rather than mRNA stability. To test this comprehensively, c-Myb protein levels were analyzed in lysates from whole-zebrafish embryos at 24 h.p.f. (Figure 3c ). Enforced expression of the miR-126 duplex reduced c-Myb protein to nearly undetectable levels, whereas the knockdown of miR-126 by MOs effectively increased c-Myb protein levels. A similar increase in c-Myb protein levels was observed when the c-myb-TP miR126 was used to block the miR-126 target site in the c-myb 3 0 UTR to disrupt endogenous miR-126/c-myb interactions. We also assayed miR-150 function, which has been shown to regulate c-Myb in human and murine cells. 19 The MO knockdown of miR-150 resulted in an increase in c-Myb protein, whereas overexpression of miR-150 caused a reduction in c-Myb protein levels, validating a physiological role of the miR-150/c-myb interaction in the zebrafish. Our results indicate that both miR-126 and miR-150 directly regulate c-Myb protein levels in vivo during embryogenesis. Zebrafish thrombocytes represent the functional equivalent of mammalian platelets. 45 Despite this functional similarity, little is known about the ontogeny of thrombocytes in zebrafish. Megakaryocytes, the precursors of mammalian platelets, have not been identified in the zebrafish kidney marrow. 20, 46 Nonetheless, many genes essential for megakaryocyte development are present in zebrafish, suggesting that their developmental program is conserved. As a novel regulator of c-Myb, we examined the role of the miR-126/c-myb interaction during thrombocyte-erythrocyte lineage commitment. In situ hybridization assays for mature markers of thrombocytes (tpoR) and erythrocytes (slc4a1) were performed after experimentally altering miR-126 and miR-150 levels (Figures 4a-l) . Functional knockdown of miR-126 by MOs targeting the miRNA or inhibition by the target protector MO, c-myb-TP miR126 , resulted in an increase in erythrocytes and a decrease in thrombocytes compared with control (Figures 4a-f ). To further demonstrate the dependence of this phenotype on the c-Myb pathway, we concurrently knocked down c-Myb expression by MO. Although complete loss of c-Myb leads to severe morphological MicroRNA-126 regulates c-Myb in hematopoiesis C Grabher et al defects, 47 titrating its knockdown demonstrated the ability to rescue the erythrocyte-thrombocyte phenotype (Figures 4g  and h) . Consistent with studies in mammalian cells, 48 forced expression of miR-150 resulted in an opposite effect, reducing c-Myb and increasing thrombocytes while decreasing erythrocyte numbers (Figures 4i and j) . Interestingly, the miR-126 loss-of-function phenotype was dominant over the miR-150 gain-of-function, in that over expression of miR-150 could not rescue the miR-126 knockdown phenotype (Figures 4k and l) . These findings were confirmed independently by FACS analyses using a double transgenic reporter line Tg(cd41:EGFP): Tg(gata1:dsRed) that expressed EGFP in thrombocytes and dsRed in erythroid cells (Figure 4m ) The ratio of gata1:dsRed þ erythroid cells compared with CD41:EGFP þ thrombocytes was 7:1 in the control injected embryos. This increased to 10:1 when miR-126 was knocked down. Interestingly, we see an even further increase in the ratio of gata1:dsRed/CD41:EGFP in the c-myb-TP miR126 condition. This may reflect more complete inhibition of the interaction between miR126 and its binding site by blocking this directly compared with MO knockdown of miR-126, in which residual miR may be present. Knockdown of c-Myb combined with knockdown of miR-126 completely abrogated the effects of the miR-126 knockdown, and supporting the in situ experiments, overexpression of miR-150 alone reduced the ratio of gata1:dsRed/CD41:EGFP by half (7:1 to 3.5:1), whereas it failed to do so in combination with miR-126 knockdown. Unfortunately, the converse experiments could not be performed because either the overexpression of miR-126 or the knockdown of miR-150 resulted in severe developmental defects that precluded analysis at later developmental stages (Supplementary Figure S1 and data not shown). For each of these two miRNAs a number of additional mRNAs contain putative seed sequences. For example, the Target Scan algorithm 13 for target prediction yields 18 putative targets for human miR-126 under the most stringent search parameters. For human miR-150, a total of 142 genes are predicted targets containing at least one seed sequence. Thus, the developmental effects of miR-126 overexpression and miR150 knockdown during embryogenesis are likely to arise from altered expression of not only c-Myb but one or more of their other target genes.
As both miR-126 and miR150 target c-myb and result in altered megakaryocyte-erythroid cell fate, we addressed the relative expression levels of miR-126 and miR-150 in developing zebrafish thrombocytes and erythroid cells using quantitative RT-PCR on RNA extracted from sorted Tg(cd41:EGFP) and Tg(gata:dsRed) from 2 d.p.f. to 4 d.p.f. We determined that the level of miR-126 is sixfold higher at 3 d.p.f. and 10-fold higher at 4 d.p.f. in cd41-EGFP þ thrombocytes compared with miR-150, whereas in contrast the levels of both miRs were similar in gata1:dsRed erythroid cells (Figure 4n ).
Discussion
In this study, we have identified miR-126 as a physiological regulator of c-Myb. We show that it is the specific interaction of miR-126 and c-myb at the identified target site that permits post-transcriptional regulation of c-Myb levels. Our observations indicate that the level of c-Myb in hematopoietic tissue is dynamically regulated by the activities of miR-126 and miR-150, and that these effects on c-Myb result in control of the thrombocyte-erythrocyte lineage decision by multipotential progenitor cells. Thus, our data support the conservation of MicroRNA-126 regulates c-Myb in hematopoiesis C Grabher et al miRNA regulatory mechanisms of c-Myb function during mammalian and zebrafish hematopoiesis. Our data suggest that these miRNAs may function through a sequential rather than an additive mechanism to control the levels of c-Myb, and that regulation of c-Myb during the thrombocyte-erythrocyte lineage decision depends preferentially on miR-126 or miR-150 at different developmental stages. Indeed, the level of miR-126 exceeds miR-150 levels at 3 d.p.f. sixfold and is 10-fold higher at 4 d.p.f. in cd41-EGFP þ thrombocytes, whereas in contrast the levels of both miRs were similar in gata1:dsRed erythroid cells. Although our study did not address more specific aspects of vessel formation, it is notable that miR-126 has been demonstrated to have a role in vascular development. 44, 49 Hemorrhages are a prominent feature of the phenotype observed in miR-126 knockdown in the studies by Fish et al. and Nicoli et al. In view of our findings, this may be a result of both loss of vascular integrity and thrombocytopenia. In addition, both miRNAs have many predicted targets, including others in the c-Myb pathway. For example, miR-126 has been suggested to target Tom1 (target of myb 1), which in turn is suggested to activate c-Myb transcriptional activity via modulation of nuclear factor-kB signaling. [50] [51] [52] On the other hand, miR-150 is predicted to target Pim1, another positive regulator of c-Myb. 53 Hence, in addition to directly regulating c-Myb, the complementary but different effects of these two miRNAs may be mediated, at least in part, by other target genes that in turn affect c-Myb function. In summary, this paper adds another level of complexity in the c-Myb regulatory pathway, and underscores the importance of animal models, in which specific subsets of cells can be tracked during development.
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The authors declare no conflicts of interest. Figure 4 MiR-126 is essential for thrombocyte-erythrocyte lineage determination. Panels a-l show the distribution of thrombocytes and erythrocytes by in situ hybridization assays for mRNAs of the thrombopoetin receptor (tpoR) and the erythrocyte-specific solute carrier 4a1 (slc4a1). All images depict the posterior blood island of zebrafish larvae at 96 h.p.f. Functional knockdown of miR-126 by MO126MB or c-mybTP miR126 resulted in increased erythrocytes and decreased thrombocytes. Concomitant knockdown of c-Myb protein with a translational start site MO (MOmyb) could rescue this effect. Enforced expression of miR-150 resulted in a reciprocal increase in thrombocytes and decreased erythrocytes. Importantly, enforced expression of miR-150 failed to rescue the miR-126 knockdown phenotype, suggesting that both miRNAs are required at this lineage fate junction. Black arrowheads indicate thrombocytes. Elevated or reduced staining for tpoR and slc4a1 is indicated with green or red arrows, respectively. Wild-type levels of thrombocytes and erythrocytes are indicated by black horizontal arrows. Panel m shows a representative FACS plot and the ratio of gata1:dsRed þ /cd41:EGFP þ cells from double transgenic animals determined by FACS analysis. The balance of erythroid-thrombocyte lineage cells is increased in MO126MB and c-mybTP miR126 compared with control. The shift favoring erythropoiesis was rescued by MOmyb but not by miR-150 overexpression, which alone caused a reciprocal decrease in the erythroidthrombocyte cell ratio. Representative data of four experiments (n) quantitative RTPCR for miR150 and miR126 in gata1:dsRed þ cells from Tg(gata1:dsRed) and EGFP þ cells from Tg(cd41:EGFP) at 2 d.p.f., 3 d.p.f. and 4 d.p.f. Data is depicted as the ratio of miR126:miR150 (each normalized to glyceraldehyde 3-phosphate dehydrogenase). Although the ratio miR126:miR150 is relatively unchanged in gata1:dsRed þ cells between 2 and 4 days of development, in cd41:EGFP þ cells miR126 concentration continuously increases to an almost 10-fold excess over miR150 at 4 d.p.f. GFP, green fluorescent protein; RFP red fluorescent protein.
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